Native Hawaiian and other Pacific Islander people are 75% more likely to die from liver cancer and 2 to 3 times more likely ...

The risk of recurrence was generally low among cervical cancer patients with no high-risk factors who underwent radical surgery without adjuvant therapy.

When she finally switched to another OB-GYN, she was officially diagnosed with cervical insufficiency. Cervical insufficiency, also referred to as an incompetent cervix, is a condition that occurs ...

Regeneron aims to advance cancer treatments through innovative research and partnerships while emphasizing the significance of their PD-1 inhibitor, Libtayo, in ongoing clinical trials.

“Our PD-1 inhibitor Libtayo is the standard of care in advanced cutaneous squamous cell carcinoma, and in clinical trials, our investigational BCMAxCD3 bispecific antibody linvoseltamab has ...

The programme focused on critical topics of HPV vaccine, cervical cancer, and the importance of cervical cancer screening. The event featured Prof Sangeeta Rai, head of the department of ...

You’ve probably heard of the four stages of cancer—but there’s another even earlier stage that experts say can make a huge difference in treating the disease. Breast cancer is one of the few ...

The kits, which employ a chip-based RT-PCR testing method, facilitate rapid and decentralised detection of eight high-risk HPV genotypes - accounting for over 96% of cervical cancer cases worldwide.

A definitive documentary with a soaring ambition: to help accelerate the elimination of cervical cancer for every woman and girl in the USA and beyond. Conquering Cervical Cancer is available to ...

One of the children was undergoing cancer treatment and one of the mothers is pregnant. Both families had lived in the country for years and had ties to their communities, according to the ...

New data show early hints of the medicine improving patient survival — the gold standard outcome of any cancer study. The drug, ivonescimab, was approved for previously untreated patients with ...

A study out this week has found evidence that a mutagenic toxin produced by some strains of Escherichia coli can trigger early onset colorectal cancer. Scientists at the University of California ...